212 related articles for article (PubMed ID: 32931952)
1. Emerging roles and potential clinical applications of noncoding RNAs in hepatocellular carcinoma.
Cao P; Jin Q; Feng L; Li H; Qin G; Zhou G
Semin Cancer Biol; 2021 Oct; 75():136-152. PubMed ID: 32931952
[TBL] [Abstract][Full Text] [Related]
2. The role of long noncoding RNAs in hepatocellular carcinoma.
Huang Z; Zhou JK; Peng Y; He W; Huang C
Mol Cancer; 2020 Apr; 19(1):77. PubMed ID: 32295598
[TBL] [Abstract][Full Text] [Related]
3. Non-coding RNA in drug resistance of hepatocellular carcinoma.
Ding B; Lou W; Xu L; Fan W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z
BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
9. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
Lu J; Li B; Xiong X; Cheng N
Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
[TBL] [Abstract][Full Text] [Related]
10. The long noncoding RNA
Ren Y; Shang J; Li J; Liu W; Zhang Z; Yuan J; Yang M
J Biol Chem; 2017 Oct; 292(43):17939-17949. PubMed ID: 28887306
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA ZSCAN16‑AS1 promotes the malignant properties of hepatocellular carcinoma by decoying microRNA‑451a and consequently increasing ATF2 expression.
Lv C; Wan Q; Shen C; Wu H; Zhou B; Wang W
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498716
[TBL] [Abstract][Full Text] [Related]
12. Targeting non-coding RNAs and N
Wu L; Zhang Y; Ren J
Biochem Pharmacol; 2024 May; 223():116153. PubMed ID: 38513741
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
Wong CM; Tsang FH; Ng IO
Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop.
Lan T; Yuan K; Yan X; Xu L; Liao H; Hao X; Wang J; Liu H; Chen X; Xie K; Li J; Liao M; Huang J; Zeng Y; Wu H
Cancer Res; 2019 Jul; 79(13):3220-3234. PubMed ID: 31101763
[TBL] [Abstract][Full Text] [Related]
15. Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.
Li C; Chen J; Zhang K; Feng B; Wang R; Chen L
Cell Physiol Biochem; 2015; 36(2):423-34. PubMed ID: 25968300
[TBL] [Abstract][Full Text] [Related]
16. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
Heo MJ; Yun J; Kim SG
Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
[TBL] [Abstract][Full Text] [Related]
17. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N
Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321
[TBL] [Abstract][Full Text] [Related]
19. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR-422a/PDK2 axis.
Wei F; Yang L; Jiang D; Pan M; Tang G; Huang M; Zhang J
Cancer Med; 2020 Apr; 9(7):2480-2490. PubMed ID: 32022476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
